Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini Department of Medicine, University of Padova, Padova 35128, ItalyCorrespondence: Gian Paolo FadiniDepartment of Medicine, University of Padova, Via Giustiniani 2, Padova 35128, ItalyTel +39 49 8214318Fax +29 49 8212184Email gianpaolo.fadini@u...
Main Authors: | Bonora BM, Avogaro A, Fadini GP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/extraglycemic-effects-of-sglt2-inhibitors-a-review-of-the-evidence-peer-reviewed-article-DMSO |
Similar Items
-
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
by: Benedetta Maria Bonora, et al.
Published: (2019-08-01) -
SGLT2 Inhibitors: the Star in the Treatment of Type 2 Diabetes?
by: Yoshifumi Saisho
Published: (2020-05-01) -
SGLT2i: beyond the glucose-lowering effect
by: Lihua Ni, et al.
Published: (2020-06-01) -
External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
by: Lisanne C. A. Smidt, et al.
Published: (2021-09-01) -
Safety and Efficacy of SGLT2 Inhibitors: A Multiple-Treatment Meta-Analysis of Clinical Decision Indicators
by: Vicente Martínez-Vizcaíno, et al.
Published: (2021-06-01)